Kadmon Holdings, Inc. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016
Assets
Current assets:
Cash and cash equivalents
Marketable debt securities, available-for-sale
Accounts receivable, net
Accounts receivable from affiliates
Inventories, net
Deferred offering costs
Prepaid expenses and other current assets
Investment, equity securities
Total current assets

Fixed assets, net
Right of use lease asset
Goodwill
Restricted cash
Investment, equity securities
Investment, at cost
Investment, equity method
Other noncurrent assets
Total assets

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Related party loan
Accrued expenses
Deferred revenue
Term debt - current
PPP loan - current
Lease liability - current
Warrant liabilities
Total current liabilities

Deferred revenue
Lease liability - noncurrent
Deferred rent
Fair market value of financial instruments - non current
Deferred tax liability
Term debt - noncurrent
Other long term liabilities
PPP loan - noncurrent
Convertible notes, net
Total liabilities
Stockholders’ equity:
Convertible preferred stock, $0.001 par value; 10,000,000 shares authorized at September 30, 2021 and December 31, 2020; 28,708 shares issued and outstanding at September 30, 2021 and December 31, 2020.
Convertible Preferred Stock
Total convertible preferred stock, $0.001 par value; 10,000,000 shares authorized at September 30, 2021 and December 31, 2020; 28,708 shares issued and outstanding at September 30, 2021 and December 31, 2020.

Common stock, $0.001 par value; 400,000,000 shares authorized at September 30, 2021 and December 31, 2020; 176,489,990 and 171,530,045 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively
Convertible Preferred Stock
Total common stock, $0.001 par value; 400,000,000 shares authorized at September 30, 2021 and December 31, 2020; 176,489,990 and 171,530,045 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively

Additional paid-in capital
Accumulated deficit
Noncontrolling interest
Accumulated other comprehensive loss
Total stockholders’ equity
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments